{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+1&page=3", "query": { "intervention": "Experimental 1", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 4235, "total_pages": 424, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+1&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental+1&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T08:16:03.973Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05798897", "title": "Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-Hodgkin Lymphoma, Adult", "Non-Hodgkin Lymphoma, Refractory", "Non-Hodgkin Lymphoma, Relapsed", "Non Hodgkin Lymphoma", "Hodgkin Lymphoma", "Hodgkin Lymphoma, Adult", "Hodgkin's Lymphoma, Relapsed, Adult" ], "interventions": [ { "name": "MT-601", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Marker Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 79, "start_date": "2023-01-02", "completion_date": "2028-02-28", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 7, "location_summary": "Duarte, California • Aurora, Colorado • Denver, Colorado + 4 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05798897" }, { "nct_id": "NCT03270085", "title": "Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Diarrhea", "Irritable Bowel Syndrome With Diarrhea", "Bile Acid Malabsorption" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2017-12-07", "completion_date": "2019-05-31", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03270085" }, { "nct_id": "NCT01028560", "title": "Allergy Immunotherapy for the Reduction of Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Wheezing", "Asthma", "Allergy" ], "interventions": [ { "name": "Allergen extracts (subcutaneous injections)", "type": "BIOLOGICAL" }, { "name": "Standard of care", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Months", "maximum_age": "3 Years", "sex": "ALL", "summary": "18 Months to 3 Years" }, "enrollment_count": 58, "start_date": "2008-10", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2019-05-28", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01028560" }, { "nct_id": "NCT01134055", "title": "Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Macular Degeneration" ], "interventions": [ { "name": "pazopanib eye drops", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "ranibizumab intravitreal injection", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 510, "start_date": "2010-06-01", "completion_date": "2012-10-01", "has_results": true, "last_update_posted_date": "2018-01-08", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 37, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Tucson, Arizona + 31 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01134055" }, { "nct_id": "NCT07469891", "title": "A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Polycythemia Vera (PV)", "Myelofibrosis (MF)", "Myeloproliferative Neoplasms (MPNs)", "Post-Polycythemia Vera Myelofibrosis", "Post-Essential Thrombocythemia Myelofibrosis", "Primary Myelofibrosis (PMF)" ], "interventions": [ { "name": "PRT12396", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Prelude Therapeutics Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2026-04-29", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 9, "location_summary": "Los Angeles, California • Denver, Colorado • Coral Springs, Florida + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Coral Springs", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07469891" }, { "nct_id": "NCT05736874", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 1407, "start_date": "2021-08-06", "completion_date": "2022-05-18", "has_results": true, "last_update_posted_date": "2023-06-18", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 87, "location_summary": "Gilbert, Arizona • Mesa, Arizona • Peoria, Arizona + 75 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "North Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05736874" }, { "nct_id": "NCT02631590", "title": "Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Biliary Carcinoma", "Gall Bladder Carcinoma", "Cholangiocarcinoma", "Gastrointestinal Tumor" ], "interventions": [ { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Copanlisib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2016-07-05", "completion_date": "2021-03-05", "has_results": true, "last_update_posted_date": "2021-08-04", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02631590" }, { "nct_id": "NCT04850313", "title": "Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bacterial Corneal Ulcer" ], "interventions": [ { "name": "ProProKera Plus®", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2021-11-09", "completion_date": "2022-09-30", "has_results": true, "last_update_posted_date": "2023-07-07", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04850313" }, { "nct_id": "NCT06549049", "title": "A Transdiagnostic Sleep Health Intervention for Veterans With PTSD", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress Disorders, Post-Traumatic", "Sleep Initiation and Maintenance Disorders" ], "interventions": [ { "name": "TranS-C for PTSD", "type": "BEHAVIORAL" }, { "name": "Sleep Psychoeducation Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 182, "start_date": "2026-10-15", "completion_date": "2029-01-31", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06549049" }, { "nct_id": "NCT03662308", "title": "Heated Vest for Persons With Spinal Cord Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries" ], "interventions": [ { "name": "Heated Vest", "type": "DEVICE" }, { "name": "Non-Heated Vest", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "68 Years", "sex": "ALL", "summary": "18 Years to 68 Years" }, "enrollment_count": 17, "start_date": "2020-02-25", "completion_date": "2022-10-31", "has_results": true, "last_update_posted_date": "2024-05-06", "last_synced_at": "2026-10-11T08:16:03.973Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03662308" } ] }